Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "chemical library screening"
Filter
Filter
Article category
Keywords
Publication year
Research Support, Non-U.S. Gov't
Detection of Inhibitors of Phenotypically Drug-tolerant Mycobacterium tuberculosis Using an In Vitro Bactericidal Screen
Ian M. Bassett , Shichun Lun , William R. Bishai , Haidan Guo , Joanna R. Kirman , Mudassar Altaf , Ronan F. O’Toole
J. Microbiol. 2013;51(5):651-658.   Published online June 25, 2013
DOI: https://doi.org/10.1007/s12275-013-3099-4
  • 46 View
  • 0 Download
  • 10 Crossref
AbstractAbstract
Many whole cell screens of chemical libraries currently in use are based on inhibition of bacterial growth. The goal of this study was to develop a chemical library screening model that enabled detection of compounds that are active against drug-tolerant non-growing cultures of Mycobacterium tuberculosis. An in vitro model of low metabolically active mycobacteria was established with 8 and 30 day old cultures of M. smegmatis and M. tuberculosis, respectively. Reduction of resazurin was used as a measure of viability and the assay was applied in screens of chemical libraries for bactericidal compounds. The model provided cells that were phenotypically-resilient to killing by first and second-line clinical drugs including rifampicin. Screening against chemical libraries identified proteasome inhibitors, NSC310551 and NSC321206, and a structurally-related series of thiosemicarbazones, as having potent killing activity towards aged cultures. The inhibitors were confirmed as active against virulent M. tuberculosis strains including multi- and extensively-drug resistant clinical isolates. Our library screen enabled detection of compounds with a potent level of bactericidal activity towards phenotypically drug-tolerant cultures of M. tuberculosis.

Citations

Citations to this article as recorded by  
  • Cytotoxicity and activity of thiosemicarbazones and semicarbazones in Mycobacterium tuberculosis: a systematic review
    Ana Paula Desiree de Oliveira, Eloísa Gibin Sampiron, Jean Eduardo Meneguello, Andressa Lorena Ieque, Katiany Rizzieri Caleffi Ferracioli, Rosilene Fressatti Cardoso, Fábio Vandresen, Regiane Bertin de Lima Scodro
    Cuadernos de Educación y Desarrollo.2024; 16(6): e4683.     CrossRef
  • High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery
    Navid J. Ayon
    Metabolites.2023; 13(5): 625.     CrossRef
  • Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery
    Summaya Perveen, Rashmi Sharma
    Biochemical Pharmacology.2022; 197: 114906.     CrossRef
  • Anti-tuberculosis treatment strategies and drug development: challenges and priorities
    Véronique A. Dartois, Eric J. Rubin
    Nature Reviews Microbiology.2022; 20(11): 685.     CrossRef
  • Identification of small molecules targeting homoserine acetyl transferase from Mycobacterium tuberculosis and Staphylococcus aureus
    Deepika Chaudhary, Avantika Singh, Mardiana Marzuki, Abhirupa Ghosh, Saqib Kidwai, Tannu Priya Gosain, Kiran Chawla, Sonu Kumar Gupta, Nisheeth Agarwal, Sudipto Saha, Yashwant Kumar, Krishan Gopal Thakur, Amit Singhal, Ramandeep Singh
    Scientific Reports.2022;[Epub]     CrossRef
  • In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection
    Tanya Parish
    Expert Opinion on Drug Discovery.2020; 15(3): 349.     CrossRef
  • The relevance of persisters in tuberculosis drug discovery
    Soma Mandal, Samuel Njikan, Anuradha Kumar, Julie V. Early, Tanya Parish
    Microbiology .2019; 165(5): 492.     CrossRef
  • Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products
    Carolina Rodrigues Felix, Rashmi Gupta, Sandra Geden, Jill Roberts, Priscilla Winder, Shirley A. Pomponi, Maria Cristina Diaz, John K. Reed, Amy E. Wright, Kyle H. Rohde
    Antimicrobial Agents and Chemotherapy.2017;[Epub]     CrossRef
  • Targeting Phenotypically TolerantMycobacterium tuberculosis
    Ben Gold, Carl Nathan, William R. Jacobs Jr., Helen McShane, Valerie Mizrahi, Ian M. Orme
    Microbiology Spectrum.2017;[Epub]     CrossRef
  • Optimization and Evaluation of 5-Styryl-Oxathiazol-2-oneMycobacterium tuberculosisProteasome Inhibitors as Potential Antitubercular Agents
    Francesco Russo, Johan Gising, Linda Åkerbladh, Annette K. Roos, Agata Naworyta, Sherry L. Mowbray, Anders Sokolowski, Ian Henderson, Torey Alling, Mai A. Bailey, Megan Files, Tanya Parish, Anders Karlén, Mats Larhed
    ChemistryOpen.2015; 4(3): 342.     CrossRef

Journal of Microbiology : Journal of Microbiology
TOP